Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-01-18

Clinical Trial Update: Botulinum Toxin Treatment for Localized Vitiligo [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating botulinum toxin for localized vitiligo has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: King Saud University | Conditions: Vitiligo | Phase 4 | Status: COMPLETED